Williams Michael A, McAllister James P, Walker Marion L, Kranz Dory A, Bergsneider Marvin, Del Bigio Marc R, Fleming Laurel, Frim David M, Gwinn Katrina, Kestle John R W, Luciano Mark G, Madsen Joseph R, Oster-Granite Mary Lou, Spinella Giovanna
Department of Neurology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
J Neurosurg. 2007 Nov;107(5 Suppl):345-57. doi: 10.3171/PED-07/11/345.
Treatment for hydrocephalus has not advanced appreciably since the advent of cerebrospinal fluid (CSF) shunts more than 50 years ago. Many questions remain that clinical and basic research could address, which in turn could improve therapeutic options. To clarify the main issues facing hydrocephalus research and to identify critical advances necessary to improve outcomes for patients with hydrocephalus, the National Institutes of Health (NIH) sponsored a workshop titled "Hydrocephalus: Myths, New Facts, and Clear Directions." The purpose of this paper is to report on the recommendations that resulted from that workshop.
The workshop convened from September 29 to October 1, 2005, in Bethesda, Maryland. Among the 150 attendees was an international group of participants, including experts in pediatric and adult hydrocephalus as well as scientists working in related fields, neurosurgeons, laboratory-based neuroscientists, neurologists, patient advocates, individuals with hydrocephalus, parents, and NIH program and intramural staff. Plenary and breakout sessions covered injury and recovery mechanisms, modeling, biomechanics, diagnosis, current treatment and outcomes, complications, quality of life, future treatments, medical devices, development of research networks and information sharing, and education and career development.
The conclusions were as follows: 1) current methods of diagnosis, treatment, and outcomes monitoring need improvement; 2) frequent complications, poor rate of shunt survival, and poor quality of life for patients lead to unsatisfactory outcomes; 3) investigators and caregivers need additional methods to monitor neurocognitive function and control of CSF variables such as pressure, flow, or pulsatility; 4) research warrants novel interdisciplinary approaches; 5) understanding of the pathophysiological and recovery mechanisms of neuronal function in hydrocephalus is poor, warranting further investigation; and 6) both basic and clinical aspects warrant expanded and innovative training programs.
The research priorities of this workshop provide critical guidance for future research in hydrocephalus, which should result in advances in knowledge, and ultimately in the treatment for this important disorder and improved outcomes in patients of all ages.
自50多年前脑脊液(CSF)分流术问世以来,脑积水的治疗进展并不显著。临床和基础研究仍可解决诸多问题,进而改善治疗选择。为阐明脑积水研究面临的主要问题,并确定改善脑积水患者治疗效果所需的关键进展,美国国立卫生研究院(NIH)主办了一场题为“脑积水:误区、新事实与明确方向”的研讨会。本文旨在报告该研讨会得出的建议。
该研讨会于2005年9月29日至10月1日在马里兰州贝塞斯达召开。150名与会者中有一个国际团队,包括小儿和成人脑积水专家、相关领域的科学家、神经外科医生、实验室神经科学家、神经科医生、患者权益倡导者、脑积水患者、患者父母以及NIH项目和内部工作人员。全体会议和分组会议涵盖损伤与恢复机制、建模、生物力学、诊断、当前治疗与结果、并发症、生活质量、未来治疗、医疗设备、研究网络的发展与信息共享,以及教育与职业发展。
得出以下结论:1)当前的诊断、治疗和结果监测方法需要改进;2)频繁的并发症、分流器存活率低以及患者生活质量差导致治疗效果不尽人意;3)研究人员和护理人员需要更多方法来监测神经认知功能以及控制脑脊液变量,如压力、流量或搏动性;4)研究需要新颖的跨学科方法;5)对脑积水患者神经元功能的病理生理和恢复机制了解不足,需要进一步研究;6)基础和临床方面都需要扩大和创新培训项目。
本次研讨会的研究重点为脑积水未来研究提供了关键指导,有望推动知识进步,最终改善这一重要疾病的治疗方法,并提高各年龄段患者的治疗效果。